Quick Answer
Uxin Ltd reported Total Revenue of $1.37 billion for fiscal year 2024.
Uxin Ltd — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.37B -33.2% |
$2.06B +25.9% |
$1.64B +148.9% |
$657.41M | — | $1.59B +140.9% |
| Revenue (ASC 606) | $1.37B -33.2% |
$2.06B +25.9% |
$1.64B +148.9% |
$657.41M | — | $1.59B +140.9% |
| Net Income | -$372.39M -171.5% |
-$137.16M +4.2% |
-$143.22M +66.0% |
-$421.22M | — | -$1.99B -30.6% |
| Diluted EPS | -$1.11 -68.2% |
-$0.66 +68.1% |
-$2.07 | — | — | — |
| Total Assets | $2.09B +190.6% |
$718.65M -42.6% |
$1.25B +1.4% |
$1.23B -53.4% |
$2.65B -62.7% |
$7.10B -3.4% |
| Cash and Equivalents | $23.34M -74.8% |
$92.71M -27.6% |
$128.02M -33.5% |
$192.60M -43.8% |
$342.50M -24.7% |
$454.89M -43.2% |
| Long-Term Debt | $7.39M -97.5% |
$291.95M | — | $233.00M | — | — |
| Stockholders Equity | -$292.85M +77.0% |
-$1.27B +15.7% |
-$1.51B +24.3% |
-$2.00B +14.9% |
-$2.34B -209.2% |
$2.15B -9.6% |
| R&D Expense | $33.82M -10.3% |
$37.70M +4.2% |
$36.20M -51.2% |
$74.14M | — | $140.01M +12.4% |
| Operating Income | -$312.50M +12.4% |
-$356.93M -28.0% |
-$278.94M +49.5% |
-$552.62M | — | -$1.29B +48.1% |
| Gross Profit | $80.57M +216.6% |
$25.44M -46.7% |
$47.72M +392.7% |
-$16.30M | — | $898.74M +274.1% |
| Shares Outstanding | — | — | — | — | 40.81M -95.4% |
887.58M +0.8% |
- Uxin Ltd reported Total Revenue of $1.37 billion for fiscal year 2024.
- Uxin Ltd showed a decrease of -33.2% in Total Revenue compared to the prior fiscal year.
- Uxin Ltd reported Revenue (ASC 606) of $1.37 billion for fiscal year 2024.
- Uxin Ltd showed a decrease of -33.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Uxin Ltd reported Net Income of -$372.39 million for fiscal year 2024.
- Uxin Ltd showed a decrease of -171.5% in Net Income compared to the prior fiscal year.
- Uxin Ltd reported Diluted EPS of $1.11 per share (loss) for fiscal year 2024.
- Uxin Ltd showed a decrease of -68.2% in Diluted EPS compared to the prior fiscal year.
- Uxin Ltd reported Total Assets of $1.95 billion for fiscal year 2024.
- Uxin Ltd showed a decrease of -6.5% in Total Assets compared to the prior fiscal year.
- Uxin Ltd reported Cash and Equivalents of $3.44 million for fiscal year 2024.
- Uxin Ltd showed a decrease of -85.3% in Cash and Equivalents compared to the prior fiscal year.
- Uxin Ltd reported Long-Term Debt of $7.39 million for fiscal year 2024.
- Uxin Ltd showed a decrease of -97.5% in Long-Term Debt compared to the prior fiscal year.
- Uxin Ltd reported Stockholders Equity of -$368.00 million for fiscal year 2024.
- Uxin Ltd showed a decrease of -25.7% in Stockholders Equity compared to the prior fiscal year.
- Uxin Ltd reported R&D Expense of $33.82 million for fiscal year 2024.
- Uxin Ltd showed a decrease of -10.3% in R&D Expense compared to the prior fiscal year.
- Uxin Ltd reported Operating Income of -$312.50 million for fiscal year 2024.
- Uxin Ltd showed an increase of +12.4% in Operating Income compared to the prior fiscal year.
- Uxin Ltd reported Gross Profit of $80.57 million for fiscal year 2024.
- Uxin Ltd showed an increase of +216.6% in Gross Profit compared to the prior fiscal year.
- Uxin Ltd reported Shares Outstanding of 40.81 million shares for fiscal year 2020.
- Uxin Ltd showed a decrease of -95.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: